Search for: "LEVIN v. MILLER et al"
Results 1 - 15
of 15
Sorted by Relevance
|
Sort by Date
3 Jun 2022, 10:58 am
DOWLING, JJ. 2019-09440 (Index No. 502489/14) [*1]Michelle Blackman, respondent, vMetropolitan Transit Authority, et al., defendants, New York City Transit Authority, et al., appellants. [read post]
3 Jun 2022, 10:58 am
DOWLING, JJ. 2019-09440 (Index No. 502489/14) [*1]Michelle Blackman, respondent, vMetropolitan Transit Authority, et al., defendants, New York City Transit Authority, et al., appellants. [read post]
3 Jun 2022, 10:58 am
DOWLING, JJ. 2019-09440 (Index No. 502489/14) [*1]Michelle Blackman, respondent, vMetropolitan Transit Authority, et al., defendants, New York City Transit Authority, et al., appellants. [read post]
3 Jun 2022, 10:58 am
DOWLING, JJ. 2019-09440 (Index No. 502489/14) [*1]Michelle Blackman, respondent, vMetropolitan Transit Authority, et al., defendants, New York City Transit Authority, et al., appellants. [read post]
29 Nov 2007, 10:55 am
Graubard Miller et al., the Appellate Division, First Department denied Ms. [read post]
24 May 2010, 7:42 am
Winn, et al. (09-987). [read post]
30 Oct 2014, 9:27 pm
Levin (D-Mich.), George Miller (D-Calif.) and Henry A. [read post]
1 May 2012, 12:58 pm
MILLER, Plaintiff-Appellant, v. [read post]
9 Apr 2014, 7:37 pm
Nash & Cynthia Robbins JJDPA (box accompanying Cahn et al.) [read post]
4 Jan 2014, 9:47 am
Jonathan Samet, et al., Institute of Medicine, Asbestos: Selected Health Effects (2006). [read post]
12 Jul 2012, 7:30 am
Case No.: 6:07-cv-839-Orl-35-KRS SECRETARY, DEPARTMENT OF CORRECTIONS, et. al., Respondents. [read post]
4 Oct 2014, 12:09 pm
Since 1663, the Royal Society has sported the motto: “Nullius in verba,” on no one’s authority. [read post]
8 Oct 2010, 2:14 pm
[et al.]. [read post]
25 Feb 2023, 6:50 pm
Although I am not a Jew, I am, following Jonathan Miller, “Jew-ish, just not the whole hog. [read post]
19 Jun 2022, 4:44 pm
The Justices of that Court, however, would probably be the first to disclaim any credibility on the causes of any disease.[3] The authors further distort the notion of signature diseases by stating that “[v]aginal adenocarcinoma in young women appears to be a signature disease associated with maternal use of DES. [read post]
